CrossBridge Bio’s pipeline includes a potential best-in-class TROP2-targeting TOP1i/ATRi dual-payload ADC anticipated to enter the clinic in 2026Acquisition provides an innovative synergistic dual ...
Dutch biotech Laigo Bio, which is pioneering novel and highly differentiated therapies using its proprietary SureTACs ...
Innovative biotechnology company CrossBridge Bio to be acquired by US pharmaceutical major Eli Lilly in up to USD 300 million ...
Researchers identified GSK3α as a key checkpoint controlling stem cell identity across multiple cell types. Inhibiting it ...
Linden Lake Labs ("L3"), an early-stage life sciences platform committed to advancing innovative therapies, today announced that its portfolio company, CrossBridge Bio, has entered into a definitive ...
April 10, 2026 / RedChip Companies will air interviews with BIO-key International, Inc. (Nasdaq:BKYI), 20/20 Biolabs, Inc.
The mill's new collection is built on three pillars: material transformation, process optimization and product longevity.
PM ET Access the webcast here Denver, CO, April 08, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company developing next ...
AllRock Bio has dosed the first patients in the Phase IIa ROCSTAR clinical trial investigating ROC-101, an oral ...
Selenis has formed a manufacturing partnership with material science company Kintra Fibers to increase production of Kintra’s ...
KCAS Bio, a global provider of harmonized spectral flow cytometry, today announced ongoing developments in its service ...